1. A combination that contains:! (a) at least one 6-dimethylaminomethyl-1- (3-methoxyphenyl) cyclohexane-1,3-diol component, and! (b) at least one non-steroidal anti-inflammatory drug (NSAID) component. ! 2. The combination in accordance with claim 1, which is characterized in that component (a) is! ! optionally in the form of one of its stereoisomers, in particular the enantiomer or diastereomer, the racemate, or in the form of a mixture of its stereoisomers, in particular enantiomers and / or diastereomers in any ratio of the components in the mixture, or its salt. ! 3. The combination according to claim 1, characterized in that component (a) is (1RS, 3RS, 6RS) -6-dimethylaminomethyl-1- (3-methoxyphenyl) cyclohexane-1,3-diol or its a salt where a hydrochloride salt or a phosphoric acid salt is preferred. ! 4. The combination in accordance with claim 1, which is characterized in that component (b) is selected from the group consisting of Acemetacin, Acetylsalicylic acid, Bufexamak, Diclofenac, Diclofenac-Sodium, Diflunisal, Dipiron (Metamizole), Metamizole-Sodium, Etenzamide, Ethofenamate, Flufenamic acid, Flurbiprofen, Ibuprofen, (+) - Ibuprofen, (-) - Ibuprofen, Indomethacin, Isoxicam, Kebuzon, Ketoprofen, Ketorolac, Lonazolac, Lornoxicam, Meclofenamofenofenufen, Meklofenamecofenu, Meklofenameconufu, +, Meclofenamecofenu, +, -Naproxen, Niflumic acid, Oxaprozin, Oxyphenbutazone, Phenylbutazone, Piroxicam, Propiphenazone, Salicylamide, Sulindac, Tenoxicam, Thiaprofenic Acid, SC560； Sulfasalazine and Tolmetin. !5. The combination in accordance with paragraph 4, which is characterized in that the component (b) is selected from the group including �1. Комбинация, которая содержит: ! (а) по меньшей мере один 6-диметиламинометил-1-(3-метоксифенил)-циклогексан-1,3-диольный компонент, и ! (б) по меньшей мере один нестероидный противовоспалительный лекарственный (НПВС) компонент. ! 2. Комбинация в соответствии с п.1, которая характеризуется тем, что компонент (а) предст
